Cian Healthcare

Pharmaceuticals & Drugs
₹25.95
+1.96%
Prev close ₹25.45
Get AI-Powered Analysis for Cian Healthcare Free Analysis → FREE View live price, charts & full analysis for Cian Healthcare →

Cian Healthcare Share Price Chart

Cian Healthcare last traded at ₹25.95 (2026-10-13). Over the past month the stock moved +75.9%, three months the stock moved +214.2%, year the stock moved +444.0%. Its closing range over 52 weeks is ₹4.81 – ₹25.95, with the latest close at its 52-week high.

Closing prices up to 2026-10-13.

About Cian Healthcare

Incorporated in 2003, Cian Healthcare Ltd is engaged in manufacturing and marketing of pharmaceutical products.[1]

Business Overview:[1][2] CHI is a fully integrated pharmaceutical company dealing in gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products.

Fundamentals

Market Cap₹51.80 Cr
52W High₹20.72
52W Low₹4.50
P/E Ratio-2.46
P/B Ratio6.08
EPS₹-8.41
Dividend Yield0%
ROE (3yr)-10%
Sales Growth (3yr)-25%

Quarterly Results

In the latest quarter (Mar 2026), Cian Healthcare reported sales of ₹17.00 crore (-39.3%) and net profit of ₹-17.00 crore (-1800.0%), compared with the same quarter last year.

Cian Healthcare quarterly results (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 202617.00-3.00-16.00-17.00-6.73
Sep 202511.00-4.00-33.00-4.00-1.68
Mar 202512.00-3.00-24.00-4.00-1.66
Sep 202419.000.00-0.10-16.00-6.21
Mar 202428.005.0018.001.000.57
Sep 202331.002.007.00-1.00-0.49
Mar 202333.005.0016.001.000.54
Sep 202235.003.009.000.00-0.11
Year-on-year change vs the same quarter last year
Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales growth-10.3%-2.9%-16.2%+3.7%-45.7%-63.6%-64.5%-39.3%
Operating profit growth-40.0%+0.0%+100.0%+66.7%-100.0%-160.0%-300.0%-160.0%
Net profit growth–––––-500.0%–-1800.0%
EPS growth-168.8%––+1325.0%–-407.4%–-1280.7%
OPM %9.0%16.0%7.0%18.0%-0.1%-24.0%-33.0%-16.0%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Annual Financials

In the latest year (Mar 2026), Cian Healthcare reported sales of ₹28.00 crore (-9.7%) and net profit of ₹-21.00 crore, compared with the previous year.

Cian Healthcare annual profit & loss (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 202628.00-6.00-23.00-21.00-8.41
Mar 202531.00-3.00-10.00-20.00-7.87
Mar 202459.008.0013.000.000.16
Mar 202368.009.0013.001.000.43
Mar 202264.005.008.00-2.00-0.91
Mar 202172.0010.0013.000.000.14
Mar 202057.008.0014.000.00-0.03
Mar 201962.008.0013.001.000.38
Year-on-year change vs the previous year
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales growth-6.1%-8.1%+26.3%-11.1%+6.3%-13.2%-47.5%-9.7%
Operating profit growth-38.5%+0.0%+25.0%-50.0%+80.0%-11.1%-137.5%–
Net profit growth-75.0%-100.0%–––-100.0%––
EPS growth-99.9%-107.9%–-750.0%–-62.8%-5018.8%–
OPM %13.0%14.0%13.0%8.0%13.0%13.0%-10.0%-23.0%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Shareholding

Promoter Holding95%

AI Analysis

No AI analysis generated yet for Cian Healthcare.

Get Free AI Stock Analysis FREE →

Latest News

No recent news available for Cian Healthcare.

Frequently Asked Questions

What is the share price of Cian Healthcare today?

Cian Healthcare shares were last quoted at ₹25.95 (+2.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.

What is the P/E ratio of Cian Healthcare?

Cian Healthcare has a price-to-earnings (P/E) ratio of -2.46 and a price-to-book (P/B) ratio of 6.08. The industry P/E is 53.45.

What is the 52-week high and low of Cian Healthcare?

The 52-week high of Cian Healthcare is ₹20.72 and the 52-week low is ₹4.50.

What is the market cap of Cian Healthcare?

The market capitalisation of Cian Healthcare is about ₹51.80 crore.

How did Cian Healthcare perform in its latest quarterly results?

In the latest quarter (Mar 2026), Cian Healthcare reported sales of ₹17.00 crore (-39.3%) and net profit of ₹-17.00 crore (-1800.0%), compared with the same quarter last year.

Is Cian Healthcare a good stock to buy?

This page is for information and is not investment advice. As per the data shown here, Cian Healthcare has a 3-year ROE of -10.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.

What is the promoter holding in Cian Healthcare?

Promoters hold about 95.00% of Cian Healthcare.

Which sector does Cian Healthcare belong to?

Cian Healthcare belongs to the Pharmaceuticals & Drugs sector.

Other Pharmaceuticals & Drugs stocks

All Pharmaceuticals & Drugs stocks · Browse all stocks A–Z

Go to live page for Cian Healthcare →